期刊文献+

汉族散发性乳腺癌患者BRCA1基因突变的研究 被引量:4

Analysis of the mutation of BRCA1 gene in 55 Sporadic women breast cancer patients in Ningxia
下载PDF
导出
摘要 目的研究宁夏地区汉族乳腺癌患者BRCA1基因突变情况及突变位置。方法抽取已经确诊55例乳腺癌患者的外周血标本,对照组为30例健康女性查体的外周血标本,应用PCR法(聚合酶链反应)和DNA序列直接测定的方法检测BRCA1基因突变。结果(1)55例乳腺癌BRCA1的突变率9.09%(5/55),其中17例早发性乳腺癌(≤35岁)BRCA1突变率23.53%(4/17),高于晚发性乳腺癌基因突变率的2.63%(1/38),差异有统计学意义(χ2=3.94,P<0.05);(2)5例BRCA1基因突变的乳腺癌中有3例ER、PR、人表皮生长因子受体2(HER-2)均为阴性,即三阴乳腺癌,其比例为60%(3/5),而非BRCA1突变的乳腺癌中三阴比例为10.00%(5/50),差异有统计学意义(χ2=5.56,P<0.05);BRCA1基因突变相关性乳腺癌淋巴结转移率为100%(5/5),高于非BRCA1基因突变相关性乳腺癌62%(31/50),差异有统计学意义(χ2=5.56,P<0.05)。结论BRCA1突变可能与宁夏地区汉族散发性乳腺癌尤其是早发性乳腺癌的发生密切相关,并与三阴乳腺癌有密切关系,且提示预后可能较差。 Objective To analyze the mutations of BRCA1 in patients with breast cancer in Ningxia. Methods By using polymerase chain reaction and direct DNA sequencing, BRCA1 mutations were detected in 55 women breast cancer cases and 30 cases of benign breast diseases. Results The frequency of BRCA1 mutation in 55 women breast cancer cases was 9. 09 % (5/55). The frequency of BRCA1 mutation in women early onset breast cancer was 23.53 % (4/17), which was higher than that in late onset group ( 1/38, 2. 36 % ) (χ2 = 3.94, P 〈0. 05 ) ; The frequency of estrogen receptor, progesterone receptor and human epidermal growth factor receptor negative (called triple -negative breast cancer) of BRCA1 mutation was 60% (3/5), which was higher than those in non BRCA1 mutation related breast cancer was 10.00% (5/50) ( χ2 = 5.56, P 〈 0.05 ), BRCA1 gene mutation - related breast cancer lymph node metastasis rate was 100% (5/5), higher than the non BRCA1 - related breast cancer gene mutation 62% (31/50) (χ2 = 5.56, P 〈 0.05). Conclusion The mutation of BRCA1 gene may be related to women breast cancer and early onset breast cancer, and also related with triple -negative breast cancer, and perhaps indicated poor prognosis.
出处 《宁夏医学杂志》 CAS 2010年第2期108-110,F0003,共4页 Ningxia Medical Journal
基金 宁夏自治区科技攻关项目(2007)
关键词 乳腺癌 BRCA1基因 基因突变 DNA序列测定 三阴乳腺癌 Breast cancer BRCAI gene Genc mutation DNA sequencing Triple -negative breast cancer
  • 相关文献

参考文献9

  • 1Irminger - Finger I, Siegel BD, Leung WC. The functions of breast cancer susceptibility gene 1 ( BRCA1 ) product and its associated proteins[J]. Biol Chem,1999, 380(2) : 117 -128.
  • 2周远征,孙强,林守清,汪健,刘斌,李京湘,周易冬,叶静,韩华,方福德.中国汉族乳腺癌家系中BRCA1和BRCA2基因的胚系突变[J].中华医学杂志,2004,84(4):294-298. 被引量:13
  • 3Armika Berganan, Anna Flodin, Yvonne Engwall, et al. A high frequency of germline BRCA1/2 mutations in western Sweden detec- ted with complementary screening techniques [ J ]. Familial Caneer,2005, 4 (2) : 89 - 96.
  • 4Philippe Maillet, PO,M,et al. Twenty - three novel BRCA1 and BRCA2 sequence variations identified in a cohort of Swiss breast and ovarian cancer families[ J ]. Cancer Genetic and Cytogenesis, 2006, 169 (1) :62- 68.
  • 5Nielsen TO, Hsu FD, Jensen K, et al. clinical characterization of the basal - like subtype of invasive breast carcinoma [ J ]. Clin Cancer Res, 2004, 10 ( 16 ) : 5367 - 5374.
  • 6Banerjee S, Reis - Filho JS, Ashley S, et al. Basal - like breast carcinomas: clinical outcome and response to chemotherapy [ J ]. J Clin Pathol,2006,59(7) :729 -735.
  • 7William DF, Kelly M, Sun P, et al. Estrogen receptor status in BRCAI and BRCA2 -Related breast cancer: the influence of age, grade, and histological type [ J]. Cancer Res, 2004, 10: 2029 - 2034.
  • 8Jose P, Emiliano H, Ana O, et al. istics defined by tissuemicroarray of hereditary breast cancer not at- tributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCAI and BRCA2 mutation carriers [ J ]. Cancer Res, 2003,9: 3606-3610.
  • 9Cipollini G, Tommasi S, Paradiso A, et al. Genetic alterations in hereditary breast cancer [ J ]. Ann Oncol, 2004,15 : 13 - 71.

二级参考文献1

共引文献12

同被引文献38

  • 1Dvorah A, Luna K, Israela L, et al. The founder mutation 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of o- varian cancer and 30% of early-onset breast cancer patients among Ashkenazi women[J]. Am J Genet, 1997,60(3) :505-514.
  • 2David BB, Josephine C, David DS, et al. A Common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals [ J ]. Cancer Res, 1996, 56 ( 15 ) :3409-3414.
  • 3Levy-Lahad E, Catane R, Eisenberg S, et al. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Isreal: frequency and differen- tial penetrance in ovarian cancer and in breast-ovarian cancer families [J]. Am J Hum Genet,1997,60(5) :1059-1067.
  • 4Friedman IS. Ostermeyer EA. Szabo CI, et al. Confirmation of breast and ovarian cancer in ten families [ J ]. Nature Genetics, 1994,8 (4) : 399-404.
  • 5Petr Pohlreich. Michal Zikan. Jana Stribrna, et al. High proportion of recurrent germline mutations in the BRCAlgene in breast and ovarian cancer patients from the Prague area [ J ]. Breast Cancer Research, 2005,7(5) : R728-736.
  • 6Vaidyanathan K, Lakhotia S, Ravishankar HM, et al. BRCA1 and BRCA2 germline mutation analysis among Indian women from south In- dia:identification of four novel mutations and high-frequency occur- rence of 185delAG mutation [ J ]. J Biosci ,2009,34 (3) :415-422.
  • 7付欣鸽,王振华,李锋,胡文浩,米开.热木,蒋金芳,李洪安.110例维吾尔族及汉族乳腺癌中BRCA1基因突变及P53蛋白表达的研究[J].中国组织化学与细胞化学杂志,2007,16(3):340-346. 被引量:6
  • 8Reis-Filho J S,Tutt A N. Triple negative tumours:a critical review [ J]. Histopathology ,2008 ,52 ( 1 ) : 108 - 18.
  • 9Krishnamurthy S, Poomima R, Challa V R, et al. Triple negative breast cmleer-our experience and review[ J]. Indian J Surg Oneol, 2012,3(1) :12 -6.
  • 10Narod S A, Salmena L. BRCA1 and BRCA2 mutations and breast cancer[J]. Discov ned,2011,12(66) :445 -53.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部